LaRocca John 4
4 · Y-mAbs Therapeutics, Inc. · Filed Jan 22, 2025
Insider Transaction Report
Form 4
LaRocca John
SVP, General Counsel & Secry
Transactions
- Award
Common Stock
2025-01-17+21,500→ 21,500 total - Award
Employee Stock Option (right to buy)
2025-01-17+42,900→ 42,900 totalExercise: $6.16Exp: 2035-01-17→ Common Stock (42,900 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 17, 2026, January 17, 2027 and January 17, 2028, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F2]Represents stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F3]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2026, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.